--- title: "Webinars - Avance Clinical" canonical: "https://www.avancecro.com/webinars/" generated: "2026-09-22T20:40:25+00:00" --- # **Webinars** [![The Phase 2 Endpoint Dilemma: Bridging Subjective Scales and Objective Measures in Neurodegenerative Trials](https://www.avancecro.com/wp-content/uploads/2026/03/03-31-26-Avance-Social-1000x1200-1-aspect-ratio-40-27.png)](https://www.avancecro.com/webinars/the-phase-2-endpoint-dilemma-bridging-subjective-scales-and-objective-measures-in-neurodegenerative-trials/) 11 March 2026 ### [The Phase 2 Endpoint Dilemma: Bridging Subjective Scales and Objective Measures in Neurodegenerative Trials](https://www.avancecro.com/webinars/the-phase-2-endpoint-dilemma-bridging-subjective-scales-and-objective-measures-in-neurodegenerative-trials/) Phase 2 neurodegenerative trials are increasingly challenged by slow disease trajectories, heterogeneous patient populations, and blunt legacy endpoints that struggle to detect treatment-related change over typical study durations. [Read more](https://www.avancecro.com/webinars/the-phase-2-endpoint-dilemma-bridging-subjective-scales-and-objective-measures-in-neurodegenerative-trials/) [![Unlocking Global Oncology Success: The Strategic Advantage of Australia & Asia for U.S. Biotechs](https://www.avancecro.com/wp-content/uploads/2025/06/Unlocking-Global-Oncology-Success-The-Strategic-Advantage-of-Australia-Asia-for-U.S.-Biotechs-1200x810.png)](https://www.avancecro.com/webinars/unlocking-global-oncology-success-the-strategic-advantage-of-australia-asia-for-u-s-biotechs/) 27 June 2025 ### [Unlocking Global Oncology Success: The Strategic Advantage of Australia & Asia for U.S. Biotechs](https://www.avancecro.com/webinars/unlocking-global-oncology-success-the-strategic-advantage-of-australia-asia-for-u-s-biotechs/) This expert panel will explore how Australia, Taiwan, and South Korea provide a strategic advantage in conducting early, mid, and late-phase oncology trials, offering speed, cost efficiency, and global scalability. [Read more](https://www.avancecro.com/webinars/unlocking-global-oncology-success-the-strategic-advantage-of-australia-asia-for-u-s-biotechs/) [![Avance Clinical Clinical Leader Solutions Expo May 2025: CRO Services – Oncology](https://www.avancecro.com/wp-content/uploads/2025/05/CRO-Expo-Webinar-1200x810.png)](https://www.avancecro.com/webinars/avance-clinical-clinical-leader-solutions-expo-may-2025-cro-services-oncology/) 21 May 2025 ### [Avance Clinical Clinical Leader Solutions Expo May 2025: CRO Services – Oncology](https://www.avancecro.com/webinars/avance-clinical-clinical-leader-solutions-expo-may-2025-cro-services-oncology/) This presentation outlines the key success factors driving high-impact oncology drug development, with a focus on translating innovative science into clinically and commercially meaningful outcomes. [Read more](https://www.avancecro.com/webinars/avance-clinical-clinical-leader-solutions-expo-may-2025-cro-services-oncology/) [![Clinical Leader Solutions Expo: Early-Phase Oncology Trials (CRO)](https://www.avancecro.com/wp-content/uploads/2024/10/thumb-1200x810.jpg)](https://www.avancecro.com/webinars/clinical-leader-solutions-expo-early-phase-oncology-trials-cro/) 14 October 2024 ### [Clinical Leader Solutions Expo: Early-Phase Oncology Trials (CRO)](https://www.avancecro.com/webinars/clinical-leader-solutions-expo-early-phase-oncology-trials-cro/) Discover an informative webinar that delves into the strategic benefits of conducting early-phase oncology clinical development across Australia and the USA. [Read more](https://www.avancecro.com/webinars/clinical-leader-solutions-expo-early-phase-oncology-trials-cro/) [![Early-Phase Oncology: Advantages in Australia & USA](https://www.avancecro.com/wp-content/uploads/2024/05/Woman-Receiving-Radiation-Therapy-Treatments-for-Breast-Cancer-1200x810.jpg)](https://www.avancecro.com/webinars/strategic-advantages-of-early-phase-oncology-clinical-development-across-australia-and-the-usa/) 6 August 2024 ### [Early-Phase Oncology: Advantages in Australia & USA](https://www.avancecro.com/webinars/strategic-advantages-of-early-phase-oncology-clinical-development-across-australia-and-the-usa/) Oncology has been and continues to be the leading priority in global drug development. 44% of all Phase I-III trials, current and planned, are tackling oncology. But as the push to combat cancer evolves, so too has the drug development arena. In the last decade, small and emerging biopharma has surged to the forefront of oncology development, comprising 70% of 2023 trial starts according to IQVIA Institute. With young, innovative, funding-conscious companies leading the charge, experienced trial partners are pivotal to commercial and patient success. [Read more](https://www.avancecro.com/webinars/strategic-advantages-of-early-phase-oncology-clinical-development-across-australia-and-the-usa/) [![Psychedelics in Focus: Clinical Trials, Transformations and Regulations](https://www.avancecro.com/wp-content/uploads/2024/05/Neuron-image-800x540.png)](https://www.avancecro.com/webinars/psychedelics-webinar/) 21 May 2024 ### [Psychedelics in Focus: Clinical Trials, Transformations and Regulations](https://www.avancecro.com/webinars/psychedelics-webinar/) Join us for an informative webinar as we delve into the world of psychedelic trials and the evolving regulatory landscape surrounding these transformative therapies. [Read more](https://www.avancecro.com/webinars/psychedelics-webinar/) ## Proven industry **experience & expertise** ### 500+ Studies in the past 5 years ### 450+ Experienced team members ### 18k+ Participants past 5 years ### 30 Years of CRO experience [View our capabilities](https://www.avancecro.com/capabilities/our-capabilities/)